Greene SL - Search Results

1

An observational study of isotretinoin recipients treated for acne in a health maintenance organization.

McElwee NE, Schumacher MC, Johnson SC, Weir TW, Greene SL, Scotvold MJ, Hunter JR, Dinan BJ, Jick H. McElwee NE, et al. Among authors: greene sl. Arch Dermatol. 1991 Mar;127(3):341-6. Arch Dermatol. 1991. PMID: 1825596

2

Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria.

Greene SL, Reed CE, Schroeter AL. Greene SL, et al. J Am Acad Dermatol. 1985 Apr;12(4):669-75. doi: 10.1016/s0190-9622(85)70092-8. J Am Acad Dermatol. 1985. PMID: 3886724 Clinical Trial.

3

Novel harm reduction measures at music festivals in Australia: Pilot implementation of the Emerging Drugs Network of Australia-Victoria toxicosurveillance methodology.

Syrjanen R, Dutch M, Greene SL, Lyons T, McKinnon G, Gerostamoulos D, Schumann JL; EDNAV Project Research Group. Syrjanen R, et al. Among authors: greene sl. Drug Alcohol Rev. 2024 Nov;43(7):2045-2054. doi: 10.1111/dar.13922. Epub 2024 Aug 19. Drug Alcohol Rev. 2024. PMID: 39161236

4

Protonitazene detection in two cases of opioid toxicity following the use of tetrahydrocannabinol vape products in Australia.

Syrjanen R, Schumann JL, Castle JW, Sharp L, Griffiths A, Blakey K, Dutch M, Maplesden J, Greene SL. Syrjanen R, et al. Among authors: greene sl. Clin Toxicol (Phila). 2024 Aug;62(8):539-541. doi: 10.1080/15563650.2024.2383692. Epub 2024 Jul 30. Clin Toxicol (Phila). 2024. PMID: 39078080

5

Co-exposure to gamma-hydroxybutyrate is associated with attenuated neuropsychiatric and stimulant effects of metamfetamine.

Greene SL, Syrjanen R, Hodgson SE, Abouchedid R, Schumann J. Greene SL, et al. Clin Toxicol (Phila). 2024 May;62(5):303-313. doi: 10.1080/15563650.2024.2353265. Epub 2024 Jun 17. Clin Toxicol (Phila). 2024. PMID: 38884342

6

Recurrent central odontogenic fibroma in a patient with nevoid basal cell carcinoma syndrome: case report and in vitro analysis.

Yadav DK, Smith CM, Zhang AB, DeVilliers P, Greene SL, Louis PJ, MacDougall M, Amm HM. Yadav DK, et al. Among authors: greene sl. Oral Surg Oral Med Oral Pathol Oral Radiol. 2024 Jul;138(1):e18-e25. doi: 10.1016/j.oooo.2024.02.015. Epub 2024 Mar 6. Oral Surg Oral Med Oral Pathol Oral Radiol. 2024. PMID: 38553309

7

Identification of clobromazolam in Australian emergency department intoxications using data-independent high-resolution mass spectrometry and the HighResNPS.com database.

Castle JW, Syrjanen R, Di Rago M, Schumann JL, Greene SL, Glowacki LL, Gerostamoulos D. Castle JW, et al. Among authors: greene sl. J Anal Toxicol. 2024 Jun 11;48(5):273-280. doi: 10.1093/jat/bkae012. J Anal Toxicol. 2024. PMID: 38459915

8

A risk-based approach to community illicit drug toxicosurveillance: operationalisation of the Emerging Drugs Network of Australia - Victoria (EDNAV) project.

Syrjanen R, Schumann JL, Lyons T, McKinnon G, Hodgson SE, Abouchedid R, Gerostamoulos D, Koutsogiannis Z, Fitzgerald J, Greene SL; EDNAV project research group. Syrjanen R, et al. Among authors: greene sl. Int J Drug Policy. 2023 Dec;122:104251. doi: 10.1016/j.drugpo.2023.104251. Epub 2023 Nov 11. Int J Drug Policy. 2023. PMID: 37952318

9

Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia - Victoria project 2020-2022.

Syrjanen R, Greene SL, Weber C, Smith JL, Hodgson SE, Abouchedid R, Gerostamoulos D, Maplesden J, Knott J, Hollerer H, Rotella JA, Graudins A, Schumann JL; EDNAV project research group. Syrjanen R, et al. Among authors: greene sl. Int J Drug Policy. 2023 Dec;122:104245. doi: 10.1016/j.drugpo.2023.104245. Epub 2023 Nov 7. Int J Drug Policy. 2023. PMID: 37944339

10

Non-fatal intoxications involving the novel benzodiazepine clonazolam: case series from the Emerging Drugs Network of Australia - Victoria project.

Syrjanen R, Greene SL, Castle JW, Di Rago M, Hodgson SE, Abouchedid R, Graudins A, Schumann JL. Syrjanen R, et al. Among authors: greene sl. Clin Toxicol (Phila). 2023 Apr;61(4):290-293. doi: 10.1080/15563650.2023.2183105. Epub 2023 Mar 29. Clin Toxicol (Phila). 2023. PMID: 36988452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters